CEMIP and familial pancreatic carcinoma: The analysis of cell migration-inducing hyaluronan binding protein (CEMIP) plus CA 19-9 improved the diagnostic value compared to CA 19-9 alone for the diagnosis of pancreatic cancer [34]; the study included a small but very heterogeneous group of patients with BPD in the control cohort, but the results must be validated.